Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1135-1140

  Dockrell, David H ^a   Prada, Jose ^a   Joncs, Mary F ^a   Patel, Robin ^a   Badley, Andrew D ^a   Harmsen, William S ^a   Ilstrup, Duane M ^a   Wiesner, Russell H ^a   Krom, Ruud A F ^a   Smith, Thomas F ^a   Paya, Carlos V ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; DIAGNOSTIC TEST; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; VIRUS INFECTION;

EID: 16944365567     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514104     Document Type: Article

References (15)

1. Salahuddin SZ, Ablashi DV, Markham PD, et al. Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 1986;234:596-601.
2. Tedder RS, Briggs M, Camcron CH, Honcss R, Robertson D, Whittle H. A novel lymphotropic herpesvirus. Lancet 1987;2:390-2.
3. Yanagi K, Harada S, Ban F, Oya A, Okabe N, Tobinai K. High prevalence of antibody to human herpesvirus-6 and decrease in liters with increase in age in Japan. J Infect Dis 1990;161:153-4.
4. Yamanishi K, Okuna T, Shiraki K, et al. Identification of human herpesvirus 6 as a causal agent for exanthem subitum. Lancet 1988;1:1065-7.
5. Irving WL, Cunningham AL. Serological diagnosis of infection with human herpesvirus type 6. Br Med J 1990;300:156-9.
6. Flamand L, Gossclin J, Stefanescu I, Ablashi D, Mcnzes J. Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 1995;85:1263-71.
7. Cone RW, Iluang ML, Hackman RC. Human herpesvirus 6 and pneumonia. Leuk Lymphoma 1994;15:235-41.
8. Ward KN, Gray JJ, Efstathiou S. Primary human herpesvirus 6 infection in a patient following liver transplantation from a seropositive donor. J Med Virol 1989;28:69-72.
9. Okuno T, Higashi K, Shiraki K, et al. Human herpesvirus 6 infection in renal transplantation. Transplantation 1990;49:519-22.
10. Sccchicro P, Carrigan DR, Asano Y, et al. Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J Infect Dis 1995;171:273-80.
11. Morris DJ, Littler E, Arrand JR, Jordan D, Mallick NP, Johnson RWG. Human herpesvirus-6 infection in renal transplant recipients [letter]. N Engl J Med 1989;320:1560-1.
12. Robert C, Agut H, Lunel-Fabiani F, Leger P. Human herpesvirus-6 and hepatitis in heart transplant recipients. Presse Med 1994;23:1209-10.
13. Asano Y, Hoshikawa T, Suga S, Yazaki T, Kondo K, Yamanishi K. Fatal fulminant hepatitis in an infant with human herpesvirus 6 infection. Lancet 1990;335:862-3.
14. Carrigan DR, Drobyski WR, Russler SK, Tapper MA, Knox KK, Ash RC. Interstitial pneumonitis associated with human herpesvirus 6 infection after bone marrow transplantation. Lancet 1991;338:147-9.
15. Ward KN, Sheldon MJ, Gray JJ. Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus 6 antibodies in immunosuppressed organ graft recipients: absence of virus cross-reactivity and evidence of virus interaction. J Med Virol 1991;34:258-67.